Table 2.
Comparison of Pathways and Variant Frequency in Vasodilator-Responsive Pulmonary Arterial Hypertension versus Vasodilator-Nonresponsive Pulmonary Arterial Hypertension
| VR-PAH (n = 17) |
VN-PAH (n = 19) |
|||
|---|---|---|---|---|
| No. of Patients with Variant | No. of Affected Genes | No. of Patients with Variant | No. of Affected Genes | |
| Wnt signaling | 13 | 14 | 11 | 12 |
| Vascular smooth muscle contraction | 7 | 6* | 1 | 1 |
| Mutated variants with 2+ IPAH | 12 | 33 | 10 | 10 |
| Extracellular matrix organization | 10 | 17 | 13 | 16 |
| TGF-β signaling | 5 | 7 | 3 | 3 |
Definition of abbreviations: IPAH = idiopathic pulmonary arterial hypertension; TGF = transforming growth factor; VN-PAH = vasodilator-nonresponsive pulmonary arterial hypertension; VR-PAH = vasodilator-responsive pulmonary arterial hypertension.
P = 0.0155.